|
 |
Messages from recent Ink subscribers: “Because we need to be reminded of what compassion and caring can do” (Steve)… “Thoughtful perspectives and discussion, wonderful guests, depth, useful suggestions to cope and resist. Snark and humor for these challenging times” (Marilen)… “I find your style and delivery calm and assured. Never hysterical, though that word describes how I feel most days. Thank you and your fellow journalists for dedicating your lives to telling the truth” (RL)… “I have seen you both question yourself and think strategically without demonizing those who hold differing opinions and watched you grow in your own perspective and encourage others to do the same” (Barbara)… “Anand gets to the why of things (Michele).” Join Steve, Marilen, RL, Barbara, and Michele, and support independent media by becoming a paid subscriber for the price of a coffee a month.
MAKE IT MAKE SENSE: Victims of success
How the White House is trying to bend medicine and industry to its will
|
| |||||||||||||||
In today’s letter: How the CDC’s latest vaccine study may be meant to hide the truth, and why CEOs might want to start thinking like labor leaders.
If The Ink helps you understand these times and this community keeps you sane, join us today.
 |
THE GIST: Keeping us in the dark on vaccines
This week, Health and Human Services Secretary Robert F. Kennedy Jr.’s Centers for Disease Control and Prevention, dominated by handpicked anti-vaccination activists, announced that it would no longer recommend all infants receive the hepatitis B vaccine at birth — despite overwhelming evidence of the vaccine’s safety and efficacy when administered as early as possible. Since the birth dose was widely introduced in 1991, the disease has been nearly eliminated in children; cases have declined by 95 percent. And that’s a good thing, since chronic infections lead to liver disease and cancer in as many as 25 percent of cases.
There was some surprise, then, when this week the Centers for Disease Control and Prevention also announced it would fund a new hepatitis B birth-dose vaccine safety study.
But that’s not good news. And here’s why...
Subscribe to The.Ink to unlock the rest.
Become a paying subscriber of The.Ink to get access to this post and other subscriber-only content.
A subscription gets you:
 | Access to all of our essays and interviews, including our daily letters that help you make sense of the world |
| The ability to join the discussion in our comment sections and subscriber-only chats |
| Membership in The Ink Book Club and an invitation to our exclusive author conversations and book talks |